Akzo Nobel N.V. (AKZOY)

newratings.com  Feb 15  Comment 
AMSTERDAM (dpa-AFX) - Paints and coatings maker Akzo Nobel NV (AKZOY.PK, AKZOY) reported that its net income attributable to shareholders for fiscal 2016 declined 1 percent to 970 million euros from 979 million euros in the prior year. However,...
newratings.com  Oct 19  Comment 
AMSTERDAM (dpa-AFX) - Dutch paints and coatings maker Akzo Nobel NV (AKZOY.PK, AKZOY) reported that its net income attributable to shareholders for the third-quarter was flat with last year at 285 million euros. But, adjusted earnings per share...
newratings.com  Jul 19  Comment 
AMSTERDAM (dpa-AFX) - Dutch paints and coatings maker Akzo Nobel NV (AKZOY.PK, AKZOY) reported Tuesday that its second-quarter net income attributable to shareholders declined 6 percent to 312 million euros from last year's 331 million euros,...
The Economic Times  Jun 2  Comment 
"Since last year, in addition to ensuring the bottom line, we now are really focussing on getting revenue growth and volume growth."
The Hindu Business Line  May 31  Comment 
Paints and coatings manufacturer Akzo Nobel has received fair trade regulator Competition Commission of India’s approval to acquire the industrial coatings business of BASF SE. In February, Akzo N...
The Hindu Business Line  May 13  Comment 
To pay additional dividend of Rs 50 apart from Rs 20 per share


Related Articles


Based in the Netherlands, Akzo Nobel N.V.is a Global Fortune 500 chemicals company, producing a vast array of goods such as human and animal pharmaceuticals, paints, stains, hospital supplies, and other products. The company operates three business segments: Coatings, Chemicals, and Pharma. The Coatings segment makes decorative, industrial and protective coatings, as well as industrial finishes, car refinishes, and other industrial products. The Chemicals segment produces specialty, functional, and commodity chemicals. Its products include pulp and paper, surfactants, polymers and base chemicals, as well as high-quality salts. The Pharma segment is engaged in research, development, manufacturing, sales and services in strategic areas of human and animal healthcare. The Pharma business is named as Organon Biosciences (OBS). This segment comprises two units: Organon, which makes prescription medicines and produces complex active pharmaceutical ingredients and Intervet, which manufactures veterinary products.

Comparison to Competitors


Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki